<DOC>
	<DOCNO>NCT00610454</DOCNO>
	<brief_summary>Subjects receive LEV adjunctive therapy 1 2 AEDs partial onset seizure subject temporarily unable take oral LEV , may require alternative route administration . The purpose trial evaluate safety tolerability 1000 3000 mg/day LEV administer 15-min IV infusion b.i.d . switch oral dose .</brief_summary>
	<brief_title>Safety Tolerability Levetiracetam Intravenous 15 Minute Infusion Subjects Suffering From Partial Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Adult outsubjects suffer partial onset seizure accord ILAE classification Epileptic Seizures ; intake levetiracetam adjunctive antiepileptic oral treatment addition one two antiepileptic drug ( AED ) . Had problem venous accessibility ; show safety issue relate administration one concomitant AEDs require medical intervention ; clinically significant ECG/lab abnormality ; administer vigabatrine ; administer felbamate less 18 month ; contraindication component study medication treatment IV formulation know allergic reaction intolerance pyrrolidone derivative .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Levetiracetam</keyword>
	<keyword>Keppra</keyword>
</DOC>